Enzymit
Company

Last deal

$10M

Amount

Series A

Stage

25.09.2024

Date

6

all rounds

$11M

Total amount

General

About Company
Enzymit designs and creates novel enzymes to streamline production processes, reduce costs and promote sustainability.

Industry

Sector :

Subsector :

founded date

01.01.2020

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Using a computational enzyme design platform, Enzymit generates 'new-to-nature' enzymes, which are combined in a bioreactor to produce desired molecules from cheap feedstock. This cell-free production method enables higher product yields at higher purity and lower costs than fermentation-based methods. Enzymit's discovery platform allows clients to access previously unseen enzymes for various applications, such as fine chemical manufacturing, foodtech, health, and biodefense. Established in 2020, Enzymit collaborates with global manufacturers across multiple industries to drive expansion and market impact.
Contacts